The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Edgewise Therapeutics Inc shares valued at $25,520 were sold by Russell Alan J on May 02 ’25. At $16.45 per share, Russell Alan J sold 1,551 shares. The insider’s holdings dropped to 18,521 shares worth approximately $0.26 million following the completion of this transaction.
Also, MOORE JOHN R sold 1,930 shares, netting a total of over 31,757 in proceeds. Following the sale of shares at $16.45 each, the insider now holds 6,531 shares.
Before that, KOCH KEVIN had sold 4,276 shares from its account. In a trade valued at $70,358, the President and CEO traded Edgewise Therapeutics Inc shares for $16.45 each. Upon closing the transaction, the insider’s holdings decreased to 4,276 shares, worth approximately $0.29 million.
As published in their initiating research note from Raymond James on July 30, 2025, Edgewise Therapeutics Inc [EWTX] has been a Strong buy and the price target has been revised to $46. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in late June. As of April 30, 2025, Guggenheim has initiated its “Buy” rating for EWTX. Earlier on April 02, 2025, Scotiabank downgraded its rating. Their new recommendation was “a Sector perform” for EWTX stock which previously was a “a Sector outperform”.
Analyzing EWTX Stock Performance
On last trading session,, Edgewise Therapeutics Inc [NASDAQ: EWTX] rose 2.01% to $14.23. The stock’s lowest price that day was $14.115, but it reached a high of $15.33 in the same session. During the last five days, there has been a drop of approximately -1.11%. Over the course of the year, Edgewise Therapeutics Inc shares have dropped approximately -25.03%.
Support And Resistance Levels for Edgewise Therapeutics Inc (EWTX)
RSI (Relative Strength Index) is 53.12 on the 14-day chart, showing neutral technical sentiment.
Is Edgewise Therapeutics Inc subject to short interest?
Stocks of Edgewise Therapeutics Inc saw a sharp steep in short interest on 2025-07-15 dropping by -1.46 million shares to 11.07 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 12.53 million shares. A decline of -13.16% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 14.37 of the overall float, the days-to-cover ratio (short ratio) decline to 14.37.
Which companies own the most shares of Edgewise Therapeutics Inc (EWTX)?
In terms of Edgewise Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 50 in the next 12 months, up nearly 258.42% from the previous closing price of $13.95. Analysts anticipate Edgewise Therapeutics Inc stock to reach 50 by 2025, with the lowest price target being 50. In spite of this, 1 analysts ranked Edgewise Therapeutics Inc stock as Buy at the end of 2025. On March 07, 2025, Scotiabank assigned a price target of “a Sector outperform” to the stock and initiated coverage with a $50.
